All News

Can European R&D play its way to the top of the international league? In an unprecedented gathering Science|Business brought together some of the leading protagonists to discuss possible tactics.

Novo Nordisk is doing its bit to reverse the Danish brain drain, offering a number of “return” fellowships to attract highly qualified expatriates back to Denmark.

While analysts have been focusing on Asian investment in R&D, its actual research output has been missing from their radar screens. They need to refocus.

The claim that over-patenting hinders the development of new treatments is not supported by the evidence, says the US Biotechnology Industry Organization.

A significant number of applications for the first round of grants from the newly established European Research Council have come from senior scientists currently living in non-EU countries.